Comparing the Effect of Melatonin, Diazepam, and Placebo on Decreasing the Level of Anxiety Preoperatively
Comparing Melatonin to Diazepam as a Premedication: a Triple-blind, Randomized, Placebo Controlled Clinical Trial
1 other identifier
interventional
87
1 country
1
Brief Summary
The goal of this clinical trial is to compare the effect of melatonin, diazepam, and placebo on the level of anxiety in patients undergoing surgery. The main question it aims to answer is: • Is melatonin effective in reducing the anxiety of patients undergoing surgery? Participants will be asked to answer a questionnaire then they will receive either melatonin, diazepam, or placebo, and then after an hour, they will answer the same questionnaire again. Researchers will compare melatonin, diazepam, and placebo to see if melatonin is as effective in reducing the level of anxiety as diazepam in patients undergoing surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 anxiety
Started Oct 2023
Shorter than P25 for phase_3 anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 2, 2023
CompletedFirst Submitted
Initial submission to the registry
October 21, 2023
CompletedFirst Posted
Study publicly available on registry
October 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2023
CompletedResults Posted
Study results publicly available
January 24, 2025
CompletedJanuary 24, 2025
December 1, 2024
28 days
October 21, 2023
July 6, 2024
December 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in the Anxiety Score Using the Visual Analogue Score for Anxiety Between Treatment Arms
VAS (Visual Analogue Score) Anxiety Scale is a 100 mm long scale. The scale is marked in millimeters from 0 to 100, where 0 correlates with no anxiety at all, and 100 correlates to anxiety as bad as possible. The maximum score is 100 and minimum 0. The patient is asked to point on the scale according to his anxiety level. The more the reduction in anxiety from baseline, the better the outcome.
Before administration of premedication, and after 1 hour from the administration of the premedication.
Change in Anxiety Score Based on The Amsterdam Preoperative Anxiety and Information Scale (APAIS) Between Treatment Arms
The Amsterdam Preoperative Anxiety and Information Scale (APAIS) is a self-reported questionnaire. The scale consists of six items, four of which assess the patient's anxiety, while the last two assess the patients' need-for-information and the patient must choose how much he agrees with each item on a scale of 1 (not at all) to 5 (very much). The scores of each item are summed to provide the total score. The minimum score possible is 6 and the maximum score is 30, the higher the score the higher the anxiety level and need for information. The scale consists of two subscales: Need for Information subscale: consists of two items (minimum score of 2 and maximum score of 10, the higher the score the more need for information). Anxiety subscale: consists of four items (minimum score of 4 and maximum score of 20, the higher the score the higher the anxiety level). The total scale is the sum of the two subscales.
Before administration of premedication, and after 1 hour from the administration of the premedication.
Secondary Outcomes (2)
Change in Sedation Between Treatment Arms
Before administration of premedication, and after 1 hour from the administration of the premedication.
Change in Orientation Between Treatment Arms
Before administration of premedication, and after 1 hour from the administration of the premedication.
Other Outcomes (4)
Change in the Anxiety Score Using the Visual Analogue Score for Anxiety Between Genders
Before administration of premedication, and after 1 hour from the administration of the premedication.
Change in Anxiety Score Based on The Amsterdam Preoperative Anxiety and Information Scale (APAIS) Between Genders
Before administration of premedication, and after 1 hour from the administration of the premedication.
Change in Sedation Between Genders
Before administration of premedication, and after 1 hour from the administration of the premedication.
- +1 more other outcomes
Study Arms (3)
Placebo
PLACEBO COMPARATORA 5mg vitamin B12 pill
Diazepam
ACTIVE COMPARATORA 5mg diazepam pill
Melatonin
EXPERIMENTALA 5mg melatonin pill
Interventions
Eligibility Criteria
You may qualify if:
- ASA 1 or 2
- Posted for general anesthesia
- Aging between 18 and 65 years
You may not qualify if:
- Allergy to any of the drugs under study
- Pregnancy
- Illiteracy
- Any mental illness
- Taking antipsychotics, antidepressants, anxiolytics, or sedatives
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jordan University Hospital
Amman, Jordan
Related Publications (1)
Ismail O, Albdour K, Jaber K, Jaber Y, Alsaras A, Younis A, Froukh U, Momani Y, Abu-Halaweh S. The efficacy of melatonin as a preoperative anxiolytic in real-world setting: a randomized controlled trial. Hosp Pract (1995). 2025 Feb;53(1):2600245. doi: 10.1080/21548331.2025.2600245. Epub 2025 Dec 9.
PMID: 41346130DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Omar Ismail
- Organization
- Jordan University Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Omar Ismail
University of Jordan
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
October 21, 2023
First Posted
October 26, 2023
Study Start
October 2, 2023
Primary Completion
October 30, 2023
Study Completion
October 30, 2023
Last Updated
January 24, 2025
Results First Posted
January 24, 2025
Record last verified: 2024-12